Bosutinib chronic myelogenous leukemia (CML) drug molecule. Tyrosine kinase inhibitor targeting Bcr-Abl and SRc family kinase. A
Bosutinib chronic myelogenous leukemia (CML) drug molecule. Tyrosine kinase inhibitor targeting Bcr-Abl and SRc family kinase. Atoms are represented as spheres with conventional color coding: hydrogen (white), carbon (grey), oxygen (red), nitrogen (blue).
Size: 8000px × 6124px
Photo credit: © molekuul.be / Alamy / Afripics
License: Royalty Free
Model Released: None
Keywords: atomic, atoms, bcr-abl, bosutinib, bosutinibe, cancer, carbon, chemical, chemistry, chlorine, chromosome, chronic, cml, composition, disease, drug, generic, hydrogen, inhibitor, kinase, leukemia, medicinal, medicine, model, molecular, molecule, myelogenous, nitrogen, oncology, oxygen, pharma, pharmaceutical, pharmacology, pharmacy, philadelphia, product, src, therapy, treatment, tumor, tyrosine
